N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide

C27H31N3O4S — CID 42990782

IUPACN-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide
SMILESCC(=O)c1ccc(NC(=O)CC2S/C(=N\c3ccc(C(C)C)cc3)N(CC3CCCO3)C2=O)cc1
InChIInChI=1S/C27H31N3O4S/c1-17(2)19-6-10-22(11-7-19)29-27-30(16-23-5-4-14-34-23)26(33)24(35-27)15-25(32)28-21-12-8-20(9-13-21)18(3)31/h6-13,17,23-24H,4-5,14-16H2,1-3H3,(H,28,32)/b29-27-
InChIKeyRJBJYEKQFHOXRH-OHYPFYFLSA-N
MW493.63 g/mol
LogP5.15
Rot. Bonds8

About N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide

N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide (PubChem CID 42990782) has the molecular formula C27H31N3O4S and a molecular weight of 493.63 g/mol. Its IUPAC name is N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide.

Molecular Properties

Compound NameN-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide
PubChem CID42990782
Molecular FormulaC27H31N3O4S
Molecular Weight493.63 g/mol
Exact Mass493.20
IUPAC NameN-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide
SMILESCC(=O)c1ccc(NC(=O)CC2S/C(=N\c3ccc(C(C)C)cc3)N(CC3CCCO3)C2=O)cc1
InChIInChI=1S/C27H31N3O4S/c1-17(2)19-6-10-22(11-7-19)29-27-30(16-23-5-4-14-34-23)26(33)24(35-27)15-25(32)28-21-12-8-20(9-13-21)18(3)31/h6-13,17,23-24H,4-5,14-16H2,1-3H3,(H,28,32)/b29-27-
InChIKeyRJBJYEKQFHOXRH-OHYPFYFLSA-N
XLogP5.15
TPSA88.07 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500493.63
LogP ≤ 55.15
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide?
The IUPAC name of N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide (CID 42990782) is N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide.
What is the SMILES notation for N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide?
The canonical SMILES for N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide is CC(=O)c1ccc(NC(=O)CC2S/C(=N\c3ccc(C(C)C)cc3)N(CC3CCCO3)C2=O)cc1.
What is the InChIKey of N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide?
The InChIKey is RJBJYEKQFHOXRH-OHYPFYFLSA-N. The full InChI is InChI=1S/C27H31N3O4S/c1-17(2)19-6-10-22(11-7-19)29-27-30(16-23-5-4-14-34-23)26(33)24(35-27)15-25(32)28-21-12-8-20(9-13-21)18(3)31/h6-13,17,23-24H,4-5,14-16H2,1-3H3,(H,28,32)/b29-27-.
What are the key properties of N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide?
N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide has a molecular weight of 493.63 g/mol, XLogP of 5.15, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-acetylphenyl)-2-[4-oxo-3-(oxolan-2-ylmethyl)-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-5-yl]acetamide is sourced from PubChem (CID 42990782), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).